Tamara Vokes to Patient Reported Outcome Measures
This is a "connection" page, showing publications Tamara Vokes has written about Patient Reported Outcome Measures.
Connection Strength
0.233
-
rhPTH(1-84) for hypoparathyroidism: a randomized study of patient-reported outcomes. Eur J Endocrinol. 2025 Jul 31; 193(2):310-319.
Score: 0.195
-
PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism. J Clin Endocrinol Metab. 2022 01 01; 107(1):e372-e385.
Score: 0.038